Active Substance: Terazosin.
Overview
Welcome to Dwaey, specifically on ITRIN 2mg page.
This medicine contains an important and useful components, as it consists of
Terazosinis available in the market in concentration
Terazosin
Prostate cancer should be ruled out before starting therapy. Patient w/ history of micturition syncope, prostate cancer, angina. Elderly. Pregnancy and lactation. Patient Counselling May impair ability to drive, operate machinery or engage in hazardous activities. Monitoring Parameters Monitor BP regularly. Lactation: Not known if excreted into breast milk; use caution
Hypertension, Benign prostatic hyperplasia
Hypersensitivity to quinazoline derivatives.
>10% Dizziness (10-20%),Asthenia (2-13%) 1-10% Hypotension (3-7%),Rhinitis/nasal congestion (2-6%),Lightheadedness (3-5%),Somnolence (3-5%),Palpitation (4%),Nausea (2-4%),Edema (3%),Sinusitis (3%),Dyspnea (2-3%),Fatigue (2.5%),Headache (2.5%),Back pain (2.4%),Flulike syndrome (2.4%),Tachycardia (2%),Amblyopia (1-2%),Blurred vision (1-2%),Impotence (1-2%),Syncope (1%)
3
Terazosin is an alpha1-adrenoceptor antagonist which blocks peripheral postsynaptic receptors resulting to decreased arterial tone. It relaxes smooth muscle of the bladder neck causing a reduction of bladder outlet obstruction.
Concomitant admin w/ phosphodiesterase-5 (PDE-5) inhibitors (e.g. sildenafil) can result in additive BP lowering effects and symptomatic hypotension. Possible significant hypotension when admin w/ other antihypertensive agents e.g. verapamil.
Information not available